Patents
Patents for C07C 35 - Compounds having at least one hydroxy or o-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring (4,656)
12/2004
12/02/2004US20040242563 potent, selective and safe inhibitors of Ca2+-activated potassium channel (Gardos channel) of erythrocytes, particularly sickle erythrocytes, and/or of mammalian cell proliferation for treating or preventing cancer, blood vessel proliferative disorders, fibrotic disorders and arteriosclerotic conditions
12/01/2004EP1480932A2 Method for production of beta-cryptoxanthin and alpha-cryptoxanthin from commercially available lutein
12/01/2004EP1309529B1 Fragrance compounds
12/01/2004EP1119538B1 Derivatives of phenantrene for medicinal use and a process for their preparation
11/2004
11/24/2004CN1549804A Insect repellent
11/24/2004CN1176887C Separating prepn process of carotenol
11/18/2004WO2004098612A2 Calcitriol analogs of uses thereof
11/17/2004EP1477468A1 Novel process for producing 1,2-diol
11/11/2004US20040225159 Fluorine-containing cyclic compounds, fluorine-containing polymerizable monomers, fluorine-containing polymers resist compositions and patterning method
11/10/2004EP1242361B1 Process of preparing tolterodine and analogues there of as well as intermediates prepared in the process
11/09/2004US6815553 Birch bark processing and the isolation of natural products from birch bark
11/04/2004WO2004094352A1 Method of hydrogenating phenol
11/04/2004WO2004094350A1 Method for extracting lutein from green plant materials
11/04/2004US20040220432 Method of extracting lutein from green plant materials
11/04/2004CA2520090A1 Method for extracting lutein from green plant materials
11/03/2004EP1473275A1 Metallized mesoporous silicate and method of oxidation with the same
11/03/2004EP1317461B1 4-cyclohexyl-1,3,2-oxazaborolidine chiral accessories
11/03/2004EP1226105A4 Method for preparing chiral ester
11/03/2004CN1173944C New vitamin-D derivatives with carbon ring or heterocyclic substitutents at C-25, process for the preparation, intermediate products and their use for producing medicaments
11/03/2004CN1173909C 20 kinds of modified vitamin D series derivatives, preparing and drug thereof
11/03/2004CN1173908C Method for converting derivative of internal inositol of buckwheat seed into its monomer and its seed
10/2004
10/28/2004WO2004092100A1 Indene derivatives as pharmaceutical agents
10/28/2004WO2004010512A3 Heteroatom-containing diamondoid transistors
10/28/2004CA2521883A1 Indene derivatives as pharmaceutical agents
10/27/2004EP1469842A2 Bicyclic cb2 cannabinoid receptor ligands
10/27/2004CN1172664C Agent for lowering prolactin
10/21/2004US20040210076 Carene epoxide intermediate that has been used as a precursor to tetrahydrocannabinoids
10/20/2004EP1468004A1 Metal complexes for use in metathesis
10/20/2004CN1537838A Method for synthesis of taxanes
10/19/2004US6806390 Hydroperoxide decomposition catalyst
10/19/2004CA2081315C Heterocyclic chiral ligands and method for catalytic asymmetric dihydroxylation of olefins
10/13/2004EP1465851A1 3-alkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and 3,3'-dialkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and processes for making them
10/13/2004EP1372807B1 Ionic liquids as selective additives for the separation of close-boiling or azeotropic mixtures
10/13/2004CN1535943A Preparation method of ortho-methyl cyclohexyl alcohol
10/12/2004US6803170 Resist composition and method for manufacturing semiconductor device using the resist composition
10/07/2004US20040199022 Process for producing adamantanol and adamantanone
10/06/2004EP1129057A4 Synthesis of n-silylated cyclopentaphenanthrene compounds
10/05/2004US6800658 A potent and safe inhibitors of mammalian cell proliferation for treating or preventing cancer, blood vessel proliferative disorders, fibrotic disorders and arteriosclerotic conditions
09/2004
09/30/2004US20040191680 Chemical resistance; radiation transparent; photoresists
09/29/2004CN1168729C Method for preparing pheophoribide A and pheophytic C by using marine alga
09/23/2004US20040186042 2,6-dimethyl-2-(4-methylpent-4-enyl)-1-oxaspiro[2.5]oct-5-ene is converted to iso- beta -bisabolol by reductive opening of the epoxy group;
09/22/2004EP1460057A1 Perfluoroadamantyl acrylate compound and intermediate therefor
09/22/2004CN1530357A Method for catalytic conversion of alkyl cyclohexanol and alkyl cyclohexanone from air oxidized alkyl cyclohexane
09/22/2004CN1167657C Process for producing mixture contg. cyclododecanone and cyclododecanol
09/16/2004WO2004078688A1 Alicyclic unsaturated compound, polymer, chemically amplified resist composition and method for forming pattern using said composition
09/16/2004US20040180954 Fluorine-containing cyclic esters, fluorine-containing cyclic alcohols, and their production processes
09/14/2004US6790998 Phenyl inden-1-one compounds
09/09/2004US20040176595 Glucocorticoid receptor modulators
09/09/2004DE10309682A1 New 1-chloro-5-methylene-7-hydroxy-9,9-dimethyl-spiro(5.5)undec-2-enes useful as antibiotics for treating infectious diseases and for preventing transmission of staphylococcal infections in cattle
09/08/2004EP1454893A1 Illudin analogs useful as antitumor agents
09/08/2004EP1454890A2 Anti-tumor Acylfulvenes
09/08/2004EP1453777A1 Functionalized higher diamondoids
09/07/2004CA2166898C Novel structural analogues of vitamin d
09/01/2004CN1525881A Microencapsulated catalyst, methods of preparation and methods of use thereof
09/01/2004CN1164548C Catalyst for hydrogenating 1,4-dimethyl hexahydroterephthalate to produce 1,4-dimethyl cyclohexanol and its preparation process
08/2004
08/31/2004US6784321 1-((2-arylsulfonyl)(3-methyl)(5-oxy)pent-3-ene)-2,6,6-trimethy lcyclohex-1-ene derivatives
08/26/2004US20040167100 Illudin analogs useful as antitumor agents
08/25/2004EP1449860A1 Novel fluoropolymer, resist compositions containing the same, and novel fluoromonomers
08/25/2004CN1524006A Ionic liquids as selective additives for separation of close-boiling or azeotropic mixtures
08/19/2004WO2004069778A1 Antimicrobial trinervitane derivatives
08/18/2004CN1522238A Process for producing adamantanol and adamantanone
08/12/2004US20040158097 Acylation of zeaxantin and oxidation of product followed by esterification to form a stable product with better bioactivation than salmonid pigmentation
08/11/2004CN1519218A Technique for catalytic decompoositing hydrogen dioxide cyclohexyl by using metalloporphyrin
08/10/2004US6774269 Cyclization of citronellal
08/05/2004WO2004024657A3 Process for oxidation of cyclohexane
08/03/2004US6770757 Method for recovering products from process solutions
07/2004
07/27/2004US6768016 Isolation of natural products from birch bark
07/21/2004EP1268367B1 Method for oxidizing hydrocarbons
07/15/2004US20040138297 Administering bicyclic diterpene compound of the labdane to treat menstrual disorders and premenstrual syndrome
07/15/2004US20040138262 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
07/08/2004WO2004039991A3 Method for producing esterified astaxanthin from esterified zeaxanthin
07/08/2004US20040133058 Ionic liquids as selective additives for separation of close-boiling or azeotropic mixtures
07/08/2004DE10196976T5 Durch reaktionskontrollierten Phasentransferkatalysator katalysiertes Oxidationsreaktionsverfahren By reaction controlled phase transfer catalyst catalyzed oxidation reaction process
07/07/2004CN1511131A Method for removing formic acid from aqueous solutions
07/07/2004CN1511130A Uncatalysed addition reactions
07/01/2004US20040127576 Estrogen receptor modulators
06/2004
06/30/2004EP1433211A2 Substituted pentacene semiconductors
06/24/2004WO2004052832A1 Fluorinated adamantane derivatives
06/24/2004WO2004041760A3 Fluorinated polymers
06/24/2004US20040121030 Extract from the pods of lupin seeds containing lupeol
06/24/2004CA2509158A1 Fluorinated adamantane derivatives
06/23/2004EP1210347B1 Carbocyclic nucleosides and process for obtaining such
06/23/2004CN1507429A Extract from the pods of lupin seeds containing lupeol
06/10/2004US20040110991 hydrogenated indene and naphthalene derivatives, e.g., 1,1,2,3,3-pentamethyl-7-(2-methylprop-2-enyloxy)-2,3,4,5,6,3A-hexahydroindene as fragrances for perfumes, colognes, toilet waters, personal care and cleaning products and air fresheners
06/08/2004US6747177 Process for the preparation of meso-zeaxanthin
06/01/2004US6743954 Therapy for vision defects
06/01/2004US6743953 Process for the preparation of xanthophyll crystals
05/2004
05/26/2004EP1261572A4 Dermatological compounds
05/26/2004EP0915819B1 Illudin analogs useful as antitumor agents
05/25/2004US6740785 Catalytic oxidation of organic substrates by transition metal complexes in organic solvent media expanded by supercritical or subcritical carbon dioxide
05/21/2004WO2004041760A2 Fluorinated polymers
05/20/2004US20040094478 With cyclohexanone and cyclohexanol, which are further processed to produce epsiloncaprolactam, formic acid is decomposed over the decomposition catalysts to form gaseous decomposition products, predominantly CO2 and H2
05/19/2004EP1420005A1 Cyclopentanone derivative
05/19/2004CN1496735A Spiro-compound used as perfume component
05/19/2004CN1150149C Method for synthesis of taxanes
05/18/2004US6737552 Supercritical fluid extraction, two different pressures; separates beta-carotene and lutein
05/13/2004WO2004039991A2 Method for producing esterified astaxanthin from esterified zeaxanthin
05/06/2004EP1237836B1 Method for producing alcohol/ketone mixtures
04/2004
04/29/2004US20040082816 Method for producting macrocyclic ketones
04/29/2004US20040082814 For production of pharmaceuticals/feed/food additives
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 47